DEUTSCHE BANK AG\ - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 52 filers reported holding ANAPTYSBIO INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$169,237
+6.4%
9,423
+20.5%
0.00%
Q2 2023$159,038
-49.5%
7,819
-46.0%
0.00%
Q1 2023$315,150
-72.0%
14,483
-60.1%
0.00%
-100.0%
Q4 2022$1,124,968
+29.3%
36,301
+6.5%
0.00%0.0%
Q3 2022$870,000
+25.4%
34,080
-0.2%
0.00%
Q2 2022$694,000
+168.0%
34,151
+226.1%
0.00%
Q1 2022$259,000
-36.4%
10,474
-10.6%
0.00%
Q4 2021$407,000
+35.2%
11,712
+5.6%
0.00%
Q3 2021$301,000
+1.3%
11,094
-3.1%
0.00%
Q2 2021$297,000
+0.3%
11,448
-16.5%
0.00%
Q1 2021$296,000
-18.2%
13,713
-18.6%
0.00%
Q4 2020$362,000
+119.4%
16,847
+50.5%
0.00%
Q3 2020$165,000
-27.3%
11,195
+10.2%
0.00%
Q2 2020$227,000
-89.0%
10,155
-93.0%
0.00%
-100.0%
Q1 2020$2,056,000
-30.9%
145,516
-20.6%
0.00%0.0%
Q4 2019$2,975,000
+955.0%
183,172
+2158.3%
0.00%
Q3 2019$282,000
-81.1%
8,111
-69.4%
0.00%
-100.0%
Q2 2019$1,494,000
+20.9%
26,507
+56.5%
0.00%0.0%
Q1 2019$1,236,000
-74.1%
16,934
-77.4%
0.00%
-66.7%
Q4 2018$4,774,000
-63.4%
74,864
-42.7%
0.00%
-25.0%
Q3 2018$13,045,000
-35.6%
130,759
-54.2%
0.00%
-33.3%
Q2 2018$20,261,000
+1.5%
285,223
+48.8%
0.01%
-40.0%
Q1 2018$19,952,000
+3.0%
191,716
-0.3%
0.01%
-16.7%
Q4 2017$19,373,000
+429.2%
192,361
+83.6%
0.01%
+300.0%
Q3 2017$3,661,000
+234.9%
104,795
+128.8%
0.00%
+200.0%
Q2 2017$1,093,000
+2702.6%
45,806
+3054.7%
0.00%
Q1 2017$39,0001,4520.00%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders